| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |